BlackRock Fund Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.39B Buy
22,184,702
+1,602,499
+8% +$97.8M 0.26% 53
2016
Q3
$1.3B Buy
20,582,203
+509,635
+3% +$33M 0.27% 54
2016
Q2
$1.24B Buy
20,072,568
+241,624
+1% +$14.7M 0.27% 53
2016
Q1
$1.13B Sell
19,830,944
-367,813
-2% -$20.5M 0.26% 56
2015
Q4
$1.2B Buy
20,198,757
+525,236
+3% +$30.3M 0.28% 55
2015
Q3
$1.07B Sell
19,673,521
-839,173
-4% -$54.6M 0.28% 52
2015
Q2
$1.38B Buy
20,512,694
+1,824,580
+10% +$119M 0.33% 44
2015
Q1
$1.09B Buy
18,688,114
+404,583
+2% +$24.4M 0.26% 54
2014
Q4
$1.2B Buy
18,283,531
+1,029,645
+6% +$64.9M 0.3% 48
2014
Q3
$997M Buy
17,253,886
+414,174
+2% +$23M 0.28% 47
2014
Q2
$950M Sell
16,839,712
-12,856
-0.1% -$674K 0.27% 48
2014
Q1
$866M Buy
16,852,568
+435,094
+3% +$22M 0.26% 51
2013
Q4
$867M Buy
16,417,474
+473,354
+3% +$23.3M 0.26% 48
2013
Q3
$713M Buy
15,944,120
+473,342
+3% +$21M 0.24% 54
2013
Q2
$640M Buy
+15,470,778
New +$677M 0.23% 57

Other funds holding ABBV

BlackRock Fund Advisors's ABBV Position: Q4 2016 in Review

BlackRock Fund Advisors increased its AbbVie (ABBV) stake by 7.8% in Q4 2016, buying an estimated $97.8M and bringing the position to 22,184,702 shares worth $1.39B. The position accounts for 0.26% of the portfolio, ranked #53.

BlackRock Fund Advisors first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • BlackRock Fund Advisors held 22,184,702 shares of AbbVie worth $1.39B as of Q4 2016.
  • BlackRock Fund Advisors bought 1,602,499 AbbVie shares in Q4 2016, an estimated $97.8M.
  • AbbVie made up 0.26% of BlackRock Fund Advisors's portfolio in Q4 2016, its #53 holding.
  • BlackRock Fund Advisors first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.